Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAltitude Group Regulatory News (ALT)

Share Price Information for Altitude Group (ALT)

Share Price is delayed by 15 minutes
Get Live Data
21.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 3.00 (15.00%)
Market Cap: £15.72m
ALT Live PriceLast checked at - London Stock Exchange

Intraday Altitude Group Share Chart

Trading Update and Director Share Awards

27 Oct 2023 07:00

RNS Number : 4755R
Altitude Group PLC
27 October 2023
Β 

27 October 2023

Β 

Altitude Group plc

("Altitude", the "Group" or the "Company")

Β 

Trading Update

and

Notice of Results

and

Director Share Awards

and

Total Voting Rights

Altitude Group PlcΒ (AIM: ALT), theΒ leading end-to-end solutions provider for branded merchandise, is pleased to provide a trading update for the six months ended 30 September 2023, ahead of the announcement of its half year results expected to be released on 28th November ("HY24").

Trading Update

The Group's financial performance in HY24 is expected to demonstrate significant year on year growth, surpassing the figures from HY23 by over 50% on revenue and nearly 40% on Adjusted Operating Profit. The Group is benefiting from strong growth in its Merchanting Division and continuing solid performance in its Services Division. This is very much in line with the Board's expectations and gives us great confidence with both the short term and long term outlook for the Company.Β 

As of September 2023, the AMPs awarded contracts have been successfully launched, per the Company's June trading update, on time and in multiple cities acrossΒ the United States. Commercial trading within these spaces has commenced. Additionally, the business development team remains active and the pipeline continues to be robust.

Nikki Stella, CEO of Altitude plc, commented; 'these results are a real testament to the incredible hard work and talent of the team assembled within the Group. On behalf of the Board I would like to thank them. We remain highly confident about the future of Altitude and look forward to further updating shareholders with our interim results in November."

Notice of Results

Β 

The Company is also looking forward to announcing its interim results for the period ended 30 September 2023 on 28 November 2023.

Director Share Awards

The Company further announces that executive directors Nichole Stella, CEO, Graham Feltham, CFO, and Deborah Wilkinson, COO (the "Executive Directors") have elected to receive 25% of the annual performance bonuses which were awarded to them under the Company's annual bonus plan for the financial year ended 31 March 2023, in Altitude shares, with the balance to be settled in cash. As a result, the Executive Directors have been issued the number of ordinary shares (the "Issue") of 0.4 pence each in the Company ("Ordinary Shares") set out next to their names in the table below. The Ordinary Shares are being issued at an effective price of 43.51 pence each.

Director

Position

Value of Deferred Bonus receivable in Ordinary Shares (Β£)

Ordinary Shares awarded

Resulting total of Ordinary Shares interested in

Resulting percentage of issued share capital

Nichole Stella

CEO

63,469

145,868

1,165,475

1.64%

Graham Feltham

CFO

36,050

82,852

225,675

0.32%

Deborah Wilkinson

COO

25,750

59,180

613,030

0.86%

Β 

Further details regarding the performance bonus are set out within the Directors' Report within the Company's 2023 Annual Report.

Β 

Admission and Total Voting Rights

Application has been made for the 287,900 new Ordinary Shares pursuant to the Issue to be admitted to trading on AIM and dealings are expected to commence on 1 November 2023 ("Admission").

The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following Admission, the Company's issued share capital will consist of 71,135,730 Ordinary Shares.

Accordingly, the figure of 71,135,730 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Β 

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation as part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and set out more details of the transactions.

Β 

1.

Details of PDMR

(a)

Name

1. Nichole Stella

2. Graham Feltham

3. Deborah WilkinsonΒ 

2.

Reason for notification

(b)

Position / status

1. Chief Executive Officer

2. Chief Financial Officer

3. Chief Operating Officer

(c)

Initial notification / amendment

Initial notification in each case

3.

Details of the Issuer

(a)

Name

Altitude Group plc

(b)

LEI

213800VACSTYYSI39R89Β 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument

Ordinary shares of 0.4p

(b)

Nature of the transaction

Award of shares under the annual performance bonus plan

(c)

Price(s) and volume

Price

Volume

1.

43.51p

145,868

2.

43.51p

82,852

3.

43.51p

59,180

(d)

Aggregated information

N/A

(e)

Date of the transaction

25 October 2023

(f)

Place of the transaction

Outside a trading venue

Β 

Β 

For enquiries, please contact:

Altitude Group plc

Nichole Stella, Chief Executive Officer

Graham Feltham, Chief Financial Officer

Β 

Via Zeus

Zeus (Nominated Adviser & Broker)

Dan Bate / David Foreman / James Edis (Investment Banking)

Dominic King (Corporate Broking)

Tel: +44 (0)161 831 1512

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTPPGAPUUPWPWQ
Date   Source Headline
8th Jun 20267:00 amRNSDirector/PDMR Shareholding
1st Jun 20268:31 amRNSExercise & Grant of Options and TVR
17th Apr 20267:00 amRNSBoard Role Change
14th Apr 20263:25 pmRNSDirector/PDMR Dealing
9th Apr 202612:00 pmRNSDirector/PDMR Dealing
31st Mar 20267:00 amRNSTrading Update
5th Mar 20263:39 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSAppointment of Independent Non-Executive Director
10th Feb 202612:32 pmRNS-RAppointment of Chief Commercial Officer
4th Feb 20267:00 amRNSAppointment of Nominated Adviser and Sole Broker
19th Jan 20261:33 pmRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
1st Dec 20259:01 amRNSPDMR Dealing
28th Nov 20257:00 amRNSChange of Registered Office
27th Nov 20254:57 pmRNSCorrection: Exercise & Grant of Options and TVR
27th Nov 20257:30 amRNSExercise & Grant of Options, PDMR Dealings and TVR
27th Nov 20257:00 amRNSInterim Results
11th Nov 20257:00 amRNSTrading Update, Board Change and Notice of Results
30th Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20257:00 amRNSResult of AGM
12th Sep 20257:00 amRNSDirector/PDMR Dealing
11th Sep 20257:00 amRNSDirector/PDMR Dealing
10th Sep 20257:00 amRNSDirector/PDMR Dealing
8th Sep 20257:00 amRNSDirector/PDMR Dealing
5th Sep 20257:00 amRNSDirector/PDMR Dealing
15th Aug 20254:20 pmRNSChange of Venue for the 2025 AGM
7th Aug 20257:00 amRNSAudited Annual Results and Notice of AGM
30th Jul 20257:00 amRNSNotice of Results
15th Jul 20257:00 amRNSBoard Changes and Trading Update
23rd Jun 20257:00 amRNSAppointment of CFO
17th Jun 20257:00 amRNSBoard Change and Trading Update
15th May 20257:00 amRNSGrant of Options and PDMR Dealings
9th May 20255:50 pmRNSDirector/PDMR Dealing
9th Apr 20257:00 amRNSExercise of Options, Director Dealings and TVR
1st Apr 20257:00 amRNSDirector/PDMR Dealing
31st Mar 20257:00 amRNSTrading Update and New University Contract Awards
28th Mar 20257:00 amRNSChange of Registered Office
11th Mar 20257:00 amRNSDirector/PDMR Dealings
6th Mar 20257:00 amRNSDirectorate Change
3rd Dec 20247:00 amRNSInterim Results
15th Nov 20247:00 amRNSTrading Update and Notice of Results
8th Oct 20244:04 pmRNSHolding(s) in Company
23rd Sep 20244:47 pmRNSResult of AGM
6th Sep 202412:30 pmRNSPosting of Annual Report and Notice of AGM
30th Jul 20247:00 amRNSAudited Annual Results and Notice of AGM
23rd Jul 20247:00 amRNSFull Year Trading Update
3rd Jun 20249:28 amRNSExercise of Options, Director Dealings and TVR
20th May 20247:00 amRNSGrant of Options and PDMR Dealings
1st May 20247:00 amRNSPre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.